Ntv Asset Management LLC Amgen Inc Transaction History

Ntv Asset Management LLC

$687 Million
Q2 2024

A detailed history of Ntv Asset Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Ntv Asset Management LLC holds 11,039 shares of AMGN stock, worth $3.49 Million. This represents 0.5% of its overall portfolio holdings.

Number of Shares

11,039

Previous 10,961 0.71%

Holding current value

$3.49 Million

Previous $3.12 Million 10.69%

% of portfolio

0.5%

Previous 0.48%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$262.75 - $319.31 $20,494 - $24,906	78 Added 0.71%	11,039 $3.45 Million
Q1 2024 May 07, 2024	BUY	$268.87 - $324.56 $9,141 - $11,035	34 Added 0.31%	10,961 $3.12 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $19,688 - $22,211	-77 Reduced 0.7%	10,927 $3.15 Million
Q3 2023 Nov 06, 2023	BUY	$218.65 - $271.46 $32,797 - $40,719	150 Added 1.38%	11,004 $2.96 Million
Q2 2023 Aug 02, 2023	BUY	$214.27 - $253.37 $21,427 - $25,337	100 Added 0.93%	10,854 $2.41 Million
Q1 2022 May 06, 2022	SELL	$219.27 - $242.57 $15,348 - $16,979	-70 Reduced 0.65%	10,754 $2.6 Million
Q4 2021 Feb 04, 2022	SELL	$198.88 - $227.6 $49,720 - $56,900	-250 Reduced 2.26%	10,824 $2.44 Million
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $153,895 - $180,307	-725 Reduced 6.14%	11,074 $2.36 Million
Q2 2021 Aug 09, 2021	SELL	$233.58 - $259.14 $71,241 - $79,037	-305 Reduced 2.52%	11,799 $2.88 Million
Q1 2021 May 10, 2021	SELL	$221.91 - $258.6 $33,286 - $38,790	-150 Reduced 1.22%	12,104 $3.01 Million
Q4 2020 Feb 05, 2021	SELL	$216.38 - $257.67 $10,819 - $12,883	-50 Reduced 0.41%	12,254 $2.82 Million
Q2 2020 Aug 07, 2020	BUY	$197.81 - $242.74 $54,397 - $66,753	275 Added 2.29%	12,304 $2.9 Million
Q1 2020 May 06, 2020	SELL	$182.24 - $241.7 $18,224 - $24,170	-100 Reduced 0.82%	12,029 $2.44 Million
Q4 2019 Jan 30, 2020	SELL	$189.21 - $243.2 $37,842 - $48,640	-200 Reduced 1.62%	12,129 $2.92 Million
Q3 2019 Nov 04, 2019	BUY	$174.11 - $208.62 $1,741 - $2,086	10 Added 0.08%	12,329 $2.39 Million
Q2 2019 Jul 29, 2019	SELL	$166.7 - $195.41 $51,510 - $60,381	-309 Reduced 2.45%	12,319 $2.27 Million
Q1 2019 Apr 29, 2019	SELL	$180.87 - $203.88 $18,087 - $20,388	-100 Reduced 0.79%	12,628 $2.4 Million
Q4 2018 Jan 28, 2019	SELL	$178.4 - $208.25 $44,600 - $52,062	-250 Reduced 1.93%	12,728 $2.48 Million
Q3 2018 Nov 08, 2018	SELL	$185.29 - $208.89 $23,161 - $26,111	-125 Reduced 0.95%	12,978 $2.69 Million
Q2 2018 Aug 06, 2018	SELL	$166.05 - $186.51 $4,151 - $4,662	-25 Reduced 0.19%	13,103 $2.42 Million
Q3 2017 Nov 06, 2017	BUY	$167.29 - $191.0 $317,851 - $362,900	1,900 Added 16.92%	13,128 $2.45 Million
Q2 2017 Aug 08, 2017	BUY	N/A	11,228	11,228 $1.93 Million

Others Institutions Holding AMGN

# of Institutions

3,073

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ntv Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ntv Asset Management LLC with notifications on news.

Account

Ntv Asset Management LLC Amgen Inc Transaction History